HIV感染与未感染者超声心动图肺动脉压升高的研究
本研究基于退伍军人老龄化队列,评估8296名转诊超声心动图退伍军人,其中2831名HIV感染者与5465名未感染者。发现HIV病毒载量>500拷贝/ml或CD4<200细胞/μl者PASP≥40 mmHg患病率更高;HIV感染者PASP≥40 mmHg死亡风险增加(aHR 1.78),无合并症者风险更高(aHR 3.61)。
要点
- HIV病毒载量>500拷贝/ml或CD4<200细胞/μl者PASP≥40 mmHg患病率更高。
- HIV感染者PASP≥40 mmHg与死亡风险增加独立相关(aHR 1.78)。
- 无常见合并症的HIV感染者中,PASP≥40 mmHg死亡风险更高(aHR 3.61)。
核心结论
- HIV感染且高病毒载量或低CD4计数者PASP升高患病率高于未感染者。
- HIV感染者死亡风险在较低PASP值即增加,且无合并症者亦存在。
研究设计与样本
- 观察性队列研究,纳入8296名转诊超声心动图退伍军人,HIV感染者与未感染者按年龄、性别、种族/族裔和临床站点匹配。
- 分析样本为2831名HIV感染者和5465名未感染者,平均随访3.8±2.6年。
主要发现
- HIV病毒载量>500拷贝/ml者PASP≥40 mmHg的OR为1.27(95%CI 1.05-1.54)。
- CD4细胞计数<200细胞/μl者PASP≥40 mmHg的OR为1.28(95%CI 1.02-1.60)。
- HIV感染者PASP≥40 mmHg较未感染者PASP<40 mmHg的调整死亡风险aHR为1.78(95%CI 1.57-2.01)。
- 无常见合并症者中,HIV感染者PASP≥40 mmHg的调整死亡风险aHR为3.61(95%CI 2.17-6.01)。
临床怎么用
- 对HIV感染者,尤其高病毒载量或低CD4计数者,应考虑筛查和监测肺动脉高压。
- HIV感染者PASP在既往认为正常的范围内也需关注死亡风险增加。
局限性
- 研究为观察性队列,仅纳入转诊超声心动图的退伍军人,可能存在选择偏倚。
- PASP为超声心动图估测值,非右心导管确诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: The epidemiology and prognostic impact of increased pulmonary pressure among HIV-infected individuals in the antiretroviral therapy era is not well described. OBJECTIVES: To examine the prevalence, clinical features, and outcomes of increased echocardiographic pulmonary pressure in HIV-infected and -uninfected individuals. METHODS: This study evaluated 8,296 veterans referred for echocardiography with reported pulmonary artery systolic pressure (PASP) estimates from the Veterans Aging Cohort study, an observational cohort of HIV-infected and -uninfected veterans matched by age, sex, race/ethnicity, and clinical site. The primary outcome was adjusted mortality by HIV status. MEASUREMENTS AND MAIN RESULTS: PASP was reported in 2,831 HIV-infected and 5,465 HIV-uninfected veterans (follow-up [mean ± SD], 3.8 ± 2.6 yr). As compared with uninfected veterans, HIV-infected veterans with HIV viral load greater than 500 copies/ml (odds ratio, 1.27; 95% confidence interval [CI], 1.05-1.54) and those with CD4 cell count less than 200 cells/μl (odds ratio, 1.28; 95% CI, 1.02-1.60) had a higher prevalence of PASP greater than or equal to 40 mm Hg. As compared with uninfected veterans with a PASP less than 40 mm Hg, HIV-infected veterans with a PASP greater than or equal to 40 mm Hg had an increased risk of death (adjusted hazard ratio, 1.78; 95% CI, 1.57-2.01). This risk persisted even among participants without prevalent comorbidities (adjusted hazard ratio, 3.61; 95% CI, 2.17-6.01). The adjusted risk of mortality in HIV-infected veterans was higher at all PASP values than in uninfected veterans, including at values currently considered to be normal. CONCLUSIONS: HIV-infected people with high HIV viral loads or low CD4 cell counts have a higher prevalence of increased PASP than uninfected people. Mortality risk in HIV-infected veterans increases at lower values of PASP than previously recognized and is present even among those without prevalent comorbidities. These findings may inform clinical decision-making regarding screening and surveillance of pulmonary hypertension in HIV-infected individuals.
引用
- Brittain EL, Duncan MS, Chang J, et al. Increased Echocardiographic Pulmonary Pressure in HIV-infected and -uninfected Individuals in the Veterans Aging Cohort Study. Am J Respir Crit Care Med. 2018. PMID: 29131651. doi:10.1164/rccm.201708-1555OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。